HBAN
50
8
ADT
58
5
RF
56
6
LUV
42
9
SHW
64
2
QCOM
51
6
OKE
39
2
WHR
47
7
URI
65
7
CFG
65
10
FTI
55
2
LOW
55
5
QRVO
52
6
PEG
51
5
AN
52
2
LYB
25
7
LEG
43
8
ICE
50
-5
MS
62
4
MAS
78
7
HBAN
50
8
ADT
58
5
RF
56
6
LUV
42
9
SHW
64
2
QCOM
51
6
OKE
39
2
WHR
47
7
URI
65
7
CFG
65
10
FTI
55
2
LOW
55
5
QRVO
52
6
PEG
51
5
AN
52
2
LYB
25
7
LEG
43
8
ICE
50
-5
MS
62
4
MAS
78
7
Financhill
Back

Rayliant Quantitative Developed Market Equity ETF Vs. Aligos Therapeutics Industry Stock Comparison

Buy
78

RAYD
Rayliant Quantitative Developed Market Equity ETF

Last Price:
$36.77
Seasonality Move:
-1.56%
Sell
23

ALGS
Aligos Therapeutics

Last Price:
$7.43
Seasonality Move:
-14.81%
Buy
78
Rayliant Quantitative Developed Market Equity ETF (RAYD) is a Buy

Is Rayliant Quantitative Developed Market Equity ETF a Buy, Sell or Hold?

  • The current Rayliant Quantitative Developed Market Equity ETF [RAYD] share price is $36.84. The Score for RAYD is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • RAYD is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Aligos Therapeutics (ALGS) is a Sell

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $7.44. The Score for ALGS is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ALGS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RAYD Stock Price Chart

What is Rayliant Quantitative Developed Market Equity ETF's stock price today?

  • The Rayliant Quantitative Developed Market Equity ETF share price today is $36.84
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAYD is experiencing selling pressure, which indicates risk of future bearish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $7.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALGS is experiencing selling pressure, which indicates risk of future bearish movement.

RAYD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.27 Buy
Relative Strength Index (14 RSI): 60.12 Buy
Chaikin Money Flow: -3020 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.04 - 36.72) Buy
Bollinger Bands (100): (32.35 - 36.21) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 42.78 Sell
Chaikin Money Flow: -56664 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.78 - 8.96) Sell
Bollinger Bands (100): (5.28 - 8.72) Buy

RAYD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.59 Buy
20-day SMA: 36.5 Buy
50-day SMA: 35.84 Buy
200-day SMA: 33.43 Buy
8-day EMA: 36.66 Buy
20-day EMA: 36.45 Buy
50-day EMA: 35.77 Buy
200-day EMA: 33.45 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.78 Sell
20-day SMA: 8.31 Sell
50-day SMA: 7.85 Sell
200-day SMA: 15.24 Sell
8-day EMA: 7.78 Sell
20-day EMA: 8.01 Sell
50-day EMA: 7.97 Sell
200-day EMA: 11.99 Sell

Rayliant Quantitative Developed Market Equity ETF Earnings Growth & RAYD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.56 per share, an increase next quarter of $0.01 per share, an increase this year of $2.64 per share, and an increase next year of $1.43 per share.

Rayliant Quantitative Developed Market Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):